Publicacións nas que colabora con José Cabezas Cerrato (36)

2004

  1. Analysis of the relationship between body mass index, insulin resistance, and beta-cell function: A cross-sectional study using the minimal model

    Metabolism: Clinical and Experimental, Vol. 53, Núm. 11, pp. 1462-1466

2003

  1. Comparison of several insulin sensitivity indices derived from basal plasma insulin and glucose levels with minimal model indices

    Hormone and Metabolic Research, Vol. 35, Núm. 1, pp. 13-17

  2. Insulin resistance in essential hypertension: A conflictive point of view [2]

    Diabetic Medicine

  3. Phenotypic gender differences in subjects with familial partial lipodystrophy (dunnigan variety) due to a nuclear lamin A/C R482W mutation

    Hormone and Metabolic Research, Vol. 35, Núm. 1, pp. 29-35

  4. Síndrome de vena cava superior y carcinoma insular de tiroides: El stent como alternativa terapéutica paliativa

    Anales de Medicina Interna, Vol. 20, Núm. 6, pp. 301-303

  5. Síndrome de vena cava superior y carcinoma insular de tiroides: el stent como alternativa terapéutica paliativa

    Anales de medicina interna, Vol. 20, Núm. 6, pp. 301-303

2002

  1. Glucose metabolism in lean patients with mild type 2 diabetes mellitus: Evidence for insulin-sensitive and insulin-resistant variants

    Metabolism: Clinical and Experimental, Vol. 51, Núm. 8, pp. 1047-1052

1999

  1. Insulin sensitivity, glucose effectiveness, and insulin secretion in nondiabetic offspring of patients with non-insulin-dependent diabetes mellitus: A cross-sectional study

    Metabolism: Clinical and Experimental, Vol. 48, Núm. 8, pp. 978-983

  2. Maintenance of blood pressure control and left ventricular performance with small doses of enalapril

    American Journal of Cardiology, Vol. 83, Núm. 5, pp. 719-723

  3. Step-down of enalapril treatment for arterial hypertension

    Hypertension, Vol. 34, Núm. 6, pp. 1287-1292

1998

  1. Both a reduced acute insulin response to glucose and lower glucose effectiveness are responsible for the worsening of intravenous glucose tolerance in healthy subjects independently of the degree of obesity

    Metabolism: Clinical and Experimental, Vol. 47, Núm. 3, pp. 313-320

  2. Effects on loft ventricular mass and function of low doses of enalapril for systemic hypertension

    American Journal of Cardiology, Vol. 81, Núm. 1, pp. 87-90

  3. L-5-hydroxytryptophan does not stimulate LH secretion directly from the pituitary in patients with gonadotrophin releasing hormone deficiency

    Clinical Endocrinology, Vol. 49, Núm. 2, pp. 203-207

  4. Minimal model of glucose metabolism: Modified equations and its application in the study of insulin sensitivity in obese subjects

    Diabetes Research and Clinical Practice, Vol. 39, Núm. 2, pp. 129-141

  5. Non-insulin-mediated glucose uptake in several insulin-resistant states in the postabsortive period

    Diabetes Research and Clinical Practice, Vol. 39, Núm. 2, pp. 107-113

  6. Reduction of QT and QTc dispersion during long-term treatment of systemic hypertension with enalapril

    American Journal of Cardiology, Vol. 81, Núm. 2, pp. 170-174

1997

  1. Influence of moderate physical exercise on insulin-mediated and non- insulin-mediated glucose uptake in healthy subjects

    Metabolism: Clinical and Experimental, Vol. 46, Núm. 2, pp. 203-209

  2. Insulin sensitivity and beta-cell function in essential hypertension and normotensive first-degree relatives of hypertensive subjects

    Diabetes and Metabolism, Vol. 23, Núm. 5, pp. 402-408

  3. L-hydroxytryptophan amplifies pulsatile secretion of LH in the follicular phase of normal women

    Clinical Endocrinology, Vol. 47, Núm. 5, pp. 555-563

  4. Lack of association between both insulin resistance and plasma insulin levels with blood pressure values in essential hypertension

    Hormone and Metabolic Research, Vol. 29, Núm. 11, pp. 561-565